Smartwatches overestimate physical activity energy expenditure during exercise, with estimation errors typically ranging from approximately 15% to 25%. HealthDay News — Smartwatches significantly ...

Rheumatic disease patients with opioid use disorder show lower DMARD use and higher acute care use than those without opioid use disorder.

Although the iceberg lettuce blamed for the nationwide Cyclospora outbreak has been recalled, officials say infections continue to rise.

Racial and ethnic disparities in pain management have been reported, from pediatric patients in the ED to older adults with cancer.

There is insufficient evidence to support routine use of lumbar supports for managing CLBP in adults, according to research.

IV ketamine provides meaningful short-term pain relief for patients with complex regional pain syndrome, though reliable predictors of treatment success remain unvalidated.

Illicit-source fentanyl exposure is linked to a significantly higher risk for harmful opioid-related outcomes vs medical-source exposure.

The FDA authorized the first dual glucose and ketone monitoring system, offering continuous real-time tracking for patients with diabetes.

Medication nonadherence in systemic lupus erythematosus is highest among younger adults facing access and scheduling barriers.

For patients with PsA or axSpA, continuation of b/tsDMARD therapy varies depending on their countries' socioeconomic status.

Adding cognitive behavioral therapy to a patient-centered opioid taper does not improve taper success but may reduce withdrawal symptoms.

Patients with rheumatic disease who use prescription opioids often experience disruptions in pain management during care transitions.